Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis. - Wikidata - awgldk - TriplyDB

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.

http://www.wikidata.org/entity/Q34806765

about

Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53 Caspase 8 polymorphisms contribute to the prognosis of advanced lung adenocarcinoma patients after platinum-based chemotherapy.Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines.Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells.Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells Luteinizing hormone inhibits cisplatin-induced apoptosis in human epithelial ovarian cancer cells The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death.Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs.Targeting TRAIL in the treatment of cancer: new developments.Enhanced cell growth inhibition by thiacremonone in paclitaxel-treated lung cancer cells.The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL.High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells.Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL.Cationic folate-mediated liposomal delivery of bis-arylidene oxindole induces efficient melanoma tumor regression.

P2860

Q27006998-C93608C0-494B-4CBE-A8D1-AA7E13046118 Q33439990-EC97C362-8885-49F7-BB52-78B3C090B819 Q33823827-0697A734-A0CF-4A39-A9EC-39D459B9B478 Q34980905-3F0E6997-B770-4298-B510-3DEB58474EAC Q35154556-E9C9EE7C-F3E0-49EA-8308-119AFB999D15 Q36640256-9259E525-115C-441D-B5B9-9A5C9E9EE671 Q36674724-8E9D8EB3-5674-4EE6-9AEB-BAE621F3EED5 Q36891653-0234DE56-E240-493E-A774-3C74211FD510 Q36992161-9D6CB200-1D0F-4CF8-8839-3F31C873627D Q38500801-9348ED39-0837-46AE-B5EC-88EC3D16CA89 Q38897286-DF9F7FBA-26F1-446F-9928-24DAD1E4CC66 Q39003096-4035E4C4-8452-4818-9E94-81AD4B2632E4 Q39050974-D218E8DD-5ADA-484D-99B3-B309EA07EF65 Q39229600-583E3E98-C7AC-4620-90CE-32046C934606 Q41228765-FE5E9E0D-6725-44B7-B7E2-A48731776521 Q42037754-A8E44A94-6132-4243-88C9-44839B0B1D56 Q50886544-656B917E-09AE-45B2-8CB4-57749460A603

P2860

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.

http://www.wikidata.org/entity/Q34806765

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Drug-induced caspase 8 upregul ...... to rhTRAIL-induced apoptosis.

@ast

Drug-induced caspase 8 upregul ...... to rhTRAIL-induced apoptosis.

@en

Drug-induced caspase 8 upregul ...... to rhTRAIL-induced apoptosis.

@nl

type

label

Drug-induced caspase 8 upregul ...... to rhTRAIL-induced apoptosis.

@ast

Drug-induced caspase 8 upregul ...... to rhTRAIL-induced apoptosis.

@en

Drug-induced caspase 8 upregul ...... to rhTRAIL-induced apoptosis.

@nl

prefLabel

Drug-induced caspase 8 upregul ...... to rhTRAIL-induced apoptosis.

@ast

Drug-induced caspase 8 upregul ...... to rhTRAIL-induced apoptosis.

@en

Drug-induced caspase 8 upregul ...... to rhTRAIL-induced apoptosis.

@nl

P1433

Q34806765-464F262D-F5B0-4431-8D98-2B38AA40099C

P1476

Q34806765-CA0AA348-6F47-485A-9D50-F373A87C91DD

P2093

Q34806765-02AAA478-9019-47E6-A776-4A599C7F1C04

Q34806765-2127119E-D98F-4338-AE2E-6237831773F9

Q34806765-404C66F8-620F-4E86-B460-8E2279D5F505

Q34806765-67C4FE73-EF64-4C40-A6D7-AAA75B3E7EF4

Q34806765-71496637-3C1A-4E68-A9AE-DEE3A918E154

Q34806765-CF0417E5-241F-49EE-AA01-18BBEC806978

Q34806765-FB68B7E5-D2EE-46D0-98DD-86D511B72331

P2860

Q34806765-00F8D72A-F7AB-471D-AC24-E9AF67C039C4

Q34806765-0551378A-8DA1-4D7B-84EF-EE2D0B8C4E6F

Q34806765-07AF29F5-3428-454A-8550-336763E6AAE9

Q34806765-07F819E8-7C64-48DA-99E7-05BAEE00F721

Q34806765-0990C1E3-B12B-4B05-B409-7123D8B07F7D

Q34806765-09FA820E-3BFB-4FD3-9678-72DE858435BA

Q34806765-0BF34DCA-28F4-465B-A58B-230866691909

Q34806765-0CC6BCE8-4BF6-4B44-8219-76B0004F3FAC

Q34806765-11656D51-C6CE-4AAA-9F67-6A8A491B28F5

Q34806765-12219639-A597-43B7-931E-E6EE7D2C6C65

P2888

Q34806765-A74F3D3C-3582-488F-8B30-D45C6735FC67

P304

Q34806765-EBCD7C3F-5A57-4060-AF1A-B8817679A391

P31

Q34806765-F6F954F8-FEF8-49B4-BD33-85F16D3F5F3B

P356

Q34806765-EE7688D9-90DD-4A9C-AE88-97DD7770F2BA

P407

Q34806765-90D69A39-9E9E-4ADB-95E8-6AD85D210C12

P433

Q34806765-2BCC6364-4DDB-4E3D-B13B-21D7635D23FC

P478

Q34806765-C4C7C365-564A-482C-A788-E1818FE569D2

P50

Q34806765-39E907F8-64AB-45B7-A9EF-AC373AC50D97

P577

Q34806765-814B1013-FBA1-49D9-BE32-D565B5E775DE

P5875

Q34806765-EADE7E18-8467-410A-B957-6D0272DB480C

P6179

Q34806765-270D9F4F-B94C-4BC2-A006-740A04D949CE

P698

Q34806765-92F4CCD8-62E2-4BEE-8955-BEDCF0C4FE94

P932

Q34806765-313973A8-4A9D-46AA-BF51-1AB6567C91A4

P356

P1433

British Journal of Cancer

P1476

Drug-induced caspase 8 upregul ...... s to rhTRAIL-induced apoptosis

@en

P2093

A G J van der Zee

http://www.w3.org/2001/XMLSchema#string

A Meijer

http://www.w3.org/2001/XMLSchema#string

A R M van der Bilt

http://www.w3.org/2001/XMLSchema#string

E W Duiker

http://www.w3.org/2001/XMLSchema#string

G J Meersma

http://www.w3.org/2001/XMLSchema#string

N Kooi

http://www.w3.org/2001/XMLSchema#string

S de Jong

http://www.w3.org/2001/XMLSchema#string

P2860

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

Identification and characterization of a new member of the TNF family that induces apoptosis

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency

The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

A unified model for apical caspase activation

Translational control in stress and apoptosis

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

P2888

P304

1278-1287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2011.84

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Elisabeth de Vries

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51046070

http://www.w3.org/2001/XMLSchema#string

P6179

1015726256

http://www.w3.org/2001/XMLSchema#string

P698

21487429

http://www.w3.org/2001/XMLSchema#string

P932

3078595

http://www.w3.org/2001/XMLSchema#string